ETON(Eton Pharmaceuticals, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $21.83M | $21.25M | $31.64M | $39.01M | $79.95M |
| 毛利润 | $19.00M | $14.32M | $21.06M | $23.41M | $42.74M |
| 营业利润 | −$1.50M | −$8.26M | −$1.19M | −$2.60M | −$844.00K |
| 净利润 | −$1.96M | −$9.02M | −$936.00K | −$3.82M | −$4.60M |
| 经营现金流 | −$4.72M | $4.82M | $6.82M | $969.00K | $10.52M |
| 自由现金流 | −$4.73M | $4.78M | $6.82M | $943.00K | $10.19M |
| 摊薄每股收益 | $-0.08 | — | — | — | — |